Hemispherx BioPharma, Inc. (NYSEMKT:HEB)

Gonna surprise everyone with an advisory committee panel that votes in favor of accelerated approval with phase 4 trials being required.

Shorting what the pumpers say to buy.

Shenanigans.

Projections don't look good

Will this be big in a year? Nahh. Will this be big in a couple months when the FDA pushes through the H1N1 kit? Sure. Riding it short term because there's decent support at 2 and it might get another launch before it sputters out.

safe bet

If FDA Approve.

Under heavy accumulation by barclays and other major players who know alot more than we do. Time to jump on baby

UltraLong play

Love this one

Pending FDA approval

Ampligen will be approved.
The Swiss have their hands all in this stuff!

Despite a dubious history for Ampligen, and some sloppy business moves, the drug will be approved. Once that happens, the likelihood of approval for a second orphan drug increases dramatically.

Snake oil.

Waiting on FDA approval for Ampligen.

There is so much pumping on little hard evidence, and a lot of smoke and mirrors being used here. Also, a large boost to the price based on the swine flu adjuvant aspect, where as it seems lost on the masses that possible FDA approval is for CFS and not a vaccination adjuvant.

Possible that it all comes together, but I wouldn't be putting my money into this murky waters at the moment.

Normally when investing in a company, I consider recommendations, then I evaluate fundamentals, and finally I make an emotional decision.

I admit that HEB is not backed by fundamentals, so I'm breaking my own rule. It's trading on hype (read: fun), and is therefore purely speculative. That's why I've only got disposable cash behind it right now.

But consider the following - there are no FDA approved drugs on the market for Chronic Fatigue Syndrome. It will need to be treated somehow, someway. Anybody else working on a solution?

Perhaps more buzzworthy is all the H1N1/H5N1 discussion. Everyone is racing for a cure. Japan - where normal people where face masks in public - thinks HEB is most likely to have it.

Consider lastly the decidedly negative articles written time and time again by Adam Feuerstein. I can't help but question his journalistic ethics - someone, if not him, stands to gain whenever his missives shrink the stock. He claims that HEB's CEO is maniuplating the news to benefit the stock price. There's a novel idea, a CEO who wants his stock price to GO UP! Of course he does - that's what CEO's of company DO! So I have to wonder, why does Feuerstein want the stock to go down? I'm hoping it's so he can buy shares cheaper!!! Guess we can all thank him for the temporary discount.

All in, I think the upside is worth the risk. No Ampligen FDA approval and no deals with Japan means $2.50/share going back to $.25 pretty quickly - sucks, I admit. But $2.50 going to $10 is a vacation to someplace tropical.

See you on the beach!

This stock is overpriced. Even if FDA approves, how far do you think this stock price would climb?

Ampligen will be approved.